Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 3, 2009, Pages 336-339

  Septimus, E J ^a   Kuper, K M ^b  

^a HCA Healthcare System   (United States)

^b Cardinal Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM; CARBAPENEMASE; CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; TOBRAMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COMMUNITY; DRUG DESIGN; DRUG RESISTANT TUBERCULOSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL; HUMAN; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; VACCINATION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; INFECTION; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 69449093124     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.122     Document Type: Short Survey

References (33)

1. Spellberg, B. et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin. Infect. Dis. 46, 155-164 (2008). (Pubitemid 351269151)
2. Hidron, A.I. et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control. Hosp. Epidemiol. 29, 996-1011 (2008).
3. Centers for Disease Control and Prevention. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza - Louisiana and Georgia, December 2006-January 2007. MMWR Mob. Mortal. Wkly. Rep. 56, 325-329 (2007).
4. Steinman, M.A., Gonzales, R., Linder, J.A. & Landefeld, C.S. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann. Intern. Med. 138, 525-533 (2003).
5. Fishman, N. Antimicrobial stewardship. Am. J. Med. 119, S53-61; discussion S62 (2006).
6. Cosgrove, S.E. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin. Infect. Dis. 42(suppl. 2), S82-S89 (2006).
7. Shehab, N., Patel, P.R., Srinivasan, A. & Budnitz, D.S. Emergency department visits for antibiotic-associated adverse events. Clin. Infect. Dis. 47, 735-743 (2008).
8. Cosgrove, S.E., Sakoulas, G., Perencevich, E.N., Schwaber, M.J., Karchmer, A.W. & Carmeli, Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin. Infect. Dis. 36(1), 53-59 (2003). (Pubitemid 36976508)
9. Cosgrove, S.E., Qi, Y., Kaye, K.S., Harbarth, S., Karchmer, A.W. & Carmeli, Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect. Control. Hosp. Epidemiol. 26, 166-174 (2005). (Pubitemid 40445022)
10. Reed, S.D. et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect. Control. Hosp. Epidemiol. 26, 175-183 (2005).
11. Schwaber, M.J. & Carmeli, Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J. Antimicrob. Chemother. 60, 913-920 (2007).
12. Schwaber, M.J., Navon-Venezia, S., Kaye, K.S., Ben-Ami, R., Schwartz, D. & Carmeli, Y. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 50, 1257-1262 (2006).
13. Tumbarello, M. et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob. Agents Chemother. 51, 1987-1994 (2007).
14. Playford, E.G., Craig, J.C. & Iredell, J.R. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J. Hosp. Infect. 65, 204-211 (2007).
15. Maragakis, L.L. & Perl, T.M. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46, 1254-1263 (2008).
16. Patel, G., Huprikar, S., Factor, S.H., Jenkins, S.G. & Calfee, D.P. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect. Control. Hosp. Epidemiol. 29, 1099-1106 (2008).
17. Boucher, H.W. et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1-12 (2009).
18. Owens, R.C. Antimicrobial stewardship: concepts and strategies in the 21st century. Diagn. Microbiol. Infect. Dis. 61, 110-128 (2008).
19. Dellit, T.H. et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 44, 159-177 (2007).
20. Patel, D., Lawson, W. & Guglielmo, B.J. Antimicrobial stewardship programs: interventions and associated outcomes. Expert Rev. Anti. Infect. Ther. 6, 209-222 (2008).
21. Carling, P., Fung, T., Killion, A., Terrin, N. & Barza, M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect. Control. Hosp. Epidemiol. 24, 699-706 (2003). (Pubitemid 37221343)
22. Fowler, S. et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J. Antimicrob. Chemother. 59, 990-995 (2007). (Pubitemid 47073372)
23. Roberts, J.A. & Lipman, J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit. Care Med. 37, 840-51; quiz 859 (2009).
24. Rea, R.S. & Capitano, B. Optimizing use of aminoglycosides in the critically ill. Semin. Respir. Crit. Care. Med. 28, 596-603 (2007).
25. Chastre, J. et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290, 2588-2598 (2003). (Pubitemid 37443289)
26. Mellon, M., Benbrook, C., Benbrook, K.L. on behalf of the Union of Concerned Scientists. Hogging it: Estimates of antimicrobial abuse in livestock. Union of Concerned Scientists 〈http://www.ucsusa.org/assets/documents/ food-and-agriculture/hog-chaps.pdf〉. Accessed 24 March 2009.
27. Johnson, J.R. et al. Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerging Infect. Dis. 13, 838-846 (2007).
28. Yokoe, D.S. et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect. Control Hosp. Epidemiol. (29 suppl. 1), S12-S21 (2008).
29. Pronovost, P. et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med. 355, 2725-2732 (2006). (Pubitemid 46021509)
30. Dellinger, E.P. et al. Hospitals collaborate to decrease surgical site infections. Am. J. Surg. 190, 9-15 (2005).
31. Trautner, B.W. & Darouiche, R.O. Catheter-associated infections: pathogenesis affects prevention. Arch. Intern. Med. 164, 842-850 (2004).
32. Carling, P.C., Parry, M.M., Rupp, M.E., Po, J.L., Dick, B. & Von Beheren, S. Improving cleaning of the environment surrounding patients in 36 acute care hospitals. Infect. Control. Hosp. Epidemiol. 29, 1035-1041 (2008). (Pubitemid 351267767)
33. Strategies to Address Antimicrobial Resistance Act. 〈http://www. idsociety.org/STAARAct.htm〉. Accessed 19 March 2009.